Jennifer L. Wilding - Concepedia

Author

Jennifer L. Wilding

John Radcliffe Hospital

Also Known As

J L Wilding, J. L. Wilding, J. Wilding, Jennifer L Wilding, Jennifer L. Wilding, Jennifer Wilding

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

John Radcliffe Hospital Cancer Research UK University of Oxford MRC Weatherall Institute of Molecular Medicine Churchill Hospital

About

Jennifer L. Wilding is an author at John Radcliffe Hospital specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	752
2	Cell Biology	5	5	700
3	Health Sciences	1	1	390
4	Gastroenterology	1	1	118
5	Immunology	1	1	118

Jennifer L. Wilding

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Cancer stem cells from colorectal cancer-derived cell lines Trevor M. Yeung, Shaan C. Gandhi, Jennifer L. Wilding, Proceedings of the National Academy of Sciences	2010	473
COSMIC: a curated database of somatic variants and clinical data for cancer Zbysław Sońdka, Nidhi Bindal Dhir, Denise Carvalho‐Silva, Nucleic Acids Research	2023	442
Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer Dmitri Mouradov, Clare Sloggett, Robert N. Jorissen, Cancer Research Colorectal Cancer BiologyGeneticsPathologyEpigeneticsTumor Biology	2014	390
Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas Nicola Fearnhead, Jennifer L. Wilding, Bruce Winney, Proceedings of the National Academy of Sciences	2004	198
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 Carol W. M. Chan, Newton A C S Wong, Ying Liu, Proceedings of the National Academy of Sciences CytokineKeratin 20Intermediate FilamentImmunologyGastroenterology	2009	118
CDX1 is an important molecular mediator of Barrett's metaplasia Newton A C S Wong, Jennifer L. Wilding, Simon Bartlett, Proceedings of the National Academy of Sciences	2005	104
Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers Lin-Ting Hsia, Neil Ashley, Djamila Ouaret, Proceedings of the National Academy of Sciences PathologyDermatologySurface Monoamine OxidaseCancer BiologyTumor Biology	2016	98
Loss of CDX1 expression in colorectal carcinoma: Promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines Newton A C S Wong, M. P. Britton, Gyu‐Seog Choi, Proceedings of the National Academy of Sciences PathologyCancer BiologyEpigeneticsTumor BiologyCdx1 Expression	2004	66
Mutations in the AXIN1 Gene in Advanced Prostate Cancer George Yardy, David Bicknell, Jennifer L. Wilding, European Urology UrologyCancer GenomicsAxin1 GeneProstatic DiseaseCancer Genetics	2008	52
Direct and immune mediated antibody targeting of <i>ERBB</i> receptors in a colorectal cancer cell-line panel Shazad Q. Ashraf, Angela M. Nicholls, Jennifer L. Wilding, Proceedings of the National Academy of Sciences	2012	47

Page 1